Pavan Battiprolu

Pavan Battiprolu

Company: Poseida Therapeutics

Job title: Executive Director & Head of Translation, Gene Therapy


Discovering how Best to Predict the Translational Success of AAV Gene Therapies 3:00 pm

• Analyzing pre-clinical and clinical data to assess the accuracy of durability predications of AAV gene therapies • Learning about novel methods to enhance durability prediction to minimize delays in clinical trials • Comparing different pre-clinical models to identify the optimal model for durabilityRead more

day: Day One AM

Panel Discussion: Exploring Vectors Beyond AAV and the Unique Durability Challenges and Opportunities They Present 4:00 pm

• Assessing immunogenicity concerns relating to non-viral vectors • Understanding their potential to enable redosing and minimize durability concerns using lentivirus vectors • Explore clinical updates of non-viral vectors and lentivirus vectors to improve durability Read more

day: Day Two AM

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.